APO Research
Talk to an analyst

APO RESEARCH · REPORT

Modified Proteomics Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Modified Proteomics Service Market Outlook and Growth Opportunities 2026

12 August 2026210 pages

Choose your research edition.

Industry ResearchModified Proteomics Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Modified Proteomics Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Modified Proteomics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Modified Proteomics Service Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Modified Proteomics Service Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Modified Proteomics Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Modified Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Modified Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Modified Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Modified Proteomics Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Modified Proteomics Service market include BGI Genomics, OmicScouts (Momentum Biotechnologies), Biodesix, Shanghai OE Biotech, Crown Bioscience, Shanghai Bioprofile, Creative Proteomics, Inotiv and MtoZ-Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Modified Proteomics Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Modified Proteomics Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Modified Proteomics Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Modified Proteomics Service market.

Modified Proteomics Service Segment by Company

BGI Genomics

OmicScouts (Momentum Biotechnologies)

Biodesix

Shanghai OE Biotech

Crown Bioscience

Shanghai Bioprofile

Creative Proteomics

Inotiv

MtoZ-Biolabs

CellCarta

Biognosys

MS Bioworks

Charles River Laboratories

Metware Biotechnology

Novogene

Evotec

RxCelerate

Shanghai Majorbio Bio-Pharm

Lc-Bio Technologies

CD Genomics

Discovery Life Sciences

Applied Biomics

VProteomics

Allumiqs

Westlake Omics

CDI Labs

Proteome Sciences

Sapient Bioanalytics

Proteomics International

Cosmos Wisdom

MRM Proteomics

Sinotech Genomics

Precision Biomarker Laboratories (PBL)

PTM BIO

Cell Signaling Technology (CST)

APTBIO

Modified Proteomics Service Segment by Type

Phosphorylation

Acetylation

Ubiquitination

Methylation

Glycosylation

Lactylation

Redox

Palmitoylation

Others

Modified Proteomics Service Segment by Application

Clinical Diagnostics

Drug Discovery

Others

Modified Proteomics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Modified Proteomics Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Modified Proteomics Service key companies, revenue, market share, and recent developments.

3. To split the Modified Proteomics Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Modified Proteomics Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Modified Proteomics Service significant trends, drivers, influence factors in global and regions.

6. To analyze Modified Proteomics Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Modified Proteomics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Modified Proteomics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Modified Proteomics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Modified Proteomics Service industry.

Chapter 3: Detailed analysis of Modified Proteomics Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Modified Proteomics Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Modified Proteomics Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Modified Proteomics Service Industry Trends Table 2. Modified Proteomics Service Industry Drivers Table 3. Modified Proteomics Service Industry Opportunities and Challenges Table 4. Modified Proteomics Service Industry Restraints Table 5. Global Modified Proteomics Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Modified Proteomics Service Revenue Share by Company (2021-2026) Table 7. Global Modified Proteomics Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Modified Proteomics Service Key Company Manufacturing Base & Headquarters Table 9. Global Modified Proteomics Service Company, Product Type & Application Table 10. Global Modified Proteomics Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Modified Proteomics Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Phosphorylation Table 15. Significant Companies of Acetylation Table 16. Significant Companies of Ubiquitination Table 17. Significant Companies of Methylation Table 18. Significant Companies of Glycosylation Table 19. Significant Companies of Lactylation Table 20. Significant Companies of Redox Table 21. Significant Companies of Palmitoylation Table 22. Significant Companies of Others Table 23. Global Modified Proteomics Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Modified Proteomics Service Sales Value by Type (2021-2026) & (US$ Million) Table 25. Global Modified Proteomics Service Sales Value by Type (2027-2032) & (US$ Million) Table 26. Global Modified Proteomics Service Sales Value Share by Type (2021-2026) Table 27. Global Modified Proteomics Service Sales Value Share by Type (2027-2032) Table 28. Significant Companies of Clinical Diagnostics Table 29. Significant Companies of Drug Discovery Table 30. Significant Companies of Others Table 31. Global Modified Proteomics Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Modified Proteomics Service Sales Value by Application (2021-2026) & (US$ Million) Table 33. Global Modified Proteomics Service Sales Value by Application (2027-2032) & (US$ Million) Table 34. Global Modified Proteomics Service Sales Value Share by Application (2021-2026) Table 35. Global Modified Proteomics Service Sales Value Share by Application (2027-2032) Table 36. Global Modified Proteomics Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Modified Proteomics Service Sales Value by Region (2021-2026) & (US$ Million) Table 38. Global Modified Proteomics Service Sales Value Share by Region (2021-2026) Table 39. Global Modified Proteomics Service Sales Value by Region (2027-2032) & (US$ Million) Table 40. Global Modified Proteomics Service Sales Value Share by Region (2027-2032) Table 41. Global Modified Proteomics Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Modified Proteomics Service Sales Value by Country (2021-2026) & (US$ Million) Table 43. Global Modified Proteomics Service Sales Value Market Share by Country (2021-2026) Table 44. Global Modified Proteomics Service Sales Value by Country (2027-2032) & (US$ Million) Table 45. Global Modified Proteomics Service Sales Value Market Share by Country (2027-2032) Table 46. BGI Genomics Company Information Table 47. BGI Genomics Business Overview Table 48. BGI Genomics Modified Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. BGI Genomics Modified Proteomics Service Product Portfolio Table 50. BGI Genomics Recent Development Table 51. OmicScouts (Momentum Biotechnologies) Company Information Table 52. OmicScouts (Momentum Biotechnologies) Business Overview Table 53. OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Product Portfolio Table 55. OmicScouts (Momentum Biotechnologies) Recent Development Table 56. Biodesix Company Information Table 57. Biodesix Business Overview Table 58. Biodesix Modified Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Biodesix Modified Proteomics Service Product Portfolio Table 60. Biodesix Recent Development Table 61. Shanghai OE Biotech Company Information Table 62. Shanghai OE Biotech Business Overview Table 63. Shanghai OE Biotech Modified Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Shanghai OE Biotech Modified Proteomics Service Product Portfolio Table 65. Shanghai OE Biotech Recent Development Table 66. Crown Bioscience Company Information Table 67. Crown Bioscience Business Overview Table 68. Crown Bioscience Modified Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Crown Bioscience Modified Proteomics Service Product Portfolio Table 70. Crown Bioscience Recent Development Table 71. Shanghai Bioprofile Company Information Table 72. Shanghai Bioprofile Business Overview Table 73. Shanghai Bioprofile Modified Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Shanghai Bioprofile Modified Proteomics Service Product Portfolio Table 75. Shanghai Bioprofile Recent Development Table 76. Creative Proteomics Company Information Table 77. Creative Proteomics Business Overview Table 78. Creative Proteomics Modified Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Creative Proteomics Modified Proteomics Service Product Portfolio Table 80. Creative Proteomics Recent Development Table 81. Inotiv Company Information Table 82. Inotiv Business Overview Table 83. Inotiv Modified Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Inotiv Modified Proteomics Service Product Portfolio Table 85. Inotiv Recent Development Table 86. MtoZ-Biolabs Company Information Table 87. MtoZ-Biolabs Business Overview Table 88. MtoZ-Biolabs Modified Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. MtoZ-Biolabs Modified Proteomics Service Product Portfolio Table 90. MtoZ-Biolabs Recent Development Table 91. CellCarta Company Information Table 92. CellCarta Business Overview Table 93. CellCarta Modified Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. CellCarta Modified Proteomics Service Product Portfolio Table 95. CellCarta Recent Development Table 96. Biognosys Company Information Table 97. Biognosys Business Overview Table 98. Biognosys Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Biognosys Modified Proteomics Service Product Portfolio Table 100. Biognosys Recent Development Table 101. MS Bioworks Company Information Table 102. MS Bioworks Business Overview Table 103. MS Bioworks Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. MS Bioworks Modified Proteomics Service Product Portfolio Table 105. MS Bioworks Recent Development Table 106. Charles River Laboratories Company Information Table 107. Charles River Laboratories Business Overview Table 108. Charles River Laboratories Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Charles River Laboratories Modified Proteomics Service Product Portfolio Table 110. Charles River Laboratories Recent Development Table 111. Metware Biotechnology Company Information Table 112. Metware Biotechnology Business Overview Table 113. Metware Biotechnology Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Metware Biotechnology Modified Proteomics Service Product Portfolio Table 115. Metware Biotechnology Recent Development Table 116. Novogene Company Information Table 117. Novogene Business Overview Table 118. Novogene Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Novogene Modified Proteomics Service Product Portfolio Table 120. Novogene Recent Development Table 121. Evotec Company Information Table 122. Evotec Business Overview Table 123. Evotec Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Evotec Modified Proteomics Service Product Portfolio Table 125. Evotec Recent Development Table 126. RxCelerate Company Information Table 127. RxCelerate Business Overview Table 128. RxCelerate Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. RxCelerate Modified Proteomics Service Product Portfolio Table 130. RxCelerate Recent Development Table 131. Shanghai Majorbio Bio-Pharm Company Information Table 132. Shanghai Majorbio Bio-Pharm Business Overview Table 133. Shanghai Majorbio Bio-Pharm Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Shanghai Majorbio Bio-Pharm Modified Proteomics Service Product Portfolio Table 135. Shanghai Majorbio Bio-Pharm Recent Development Table 136. Lc-Bio Technologies Company Information Table 137. Lc-Bio Technologies Business Overview Table 138. Lc-Bio Technologies Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Lc-Bio Technologies Modified Proteomics Service Product Portfolio Table 140. Lc-Bio Technologies Recent Development Table 141. CD Genomics Company Information Table 142. CD Genomics Business Overview Table 143. CD Genomics Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. CD Genomics Modified Proteomics Service Product Portfolio Table 145. CD Genomics Recent Development Table 146. Discovery Life Sciences Company Information Table 147. Discovery Life Sciences Business Overview Table 148. Discovery Life Sciences Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Discovery Life Sciences Modified Proteomics Service Product Portfolio Table 150. Discovery Life Sciences Recent Development Table 151. Applied Biomics Company Information Table 152. Applied Biomics Business Overview Table 153. Applied Biomics Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Applied Biomics Modified Proteomics Service Product Portfolio Table 155. Applied Biomics Recent Development Table 156. VProteomics Company Information Table 157. VProteomics Business Overview Table 158. VProteomics Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. VProteomics Modified Proteomics Service Product Portfolio Table 160. VProteomics Recent Development Table 161. Allumiqs Company Information Table 162. Allumiqs Business Overview Table 163. Allumiqs Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. Allumiqs Modified Proteomics Service Product Portfolio Table 165. Allumiqs Recent Development Table 166. Westlake Omics Company Information Table 167. Westlake Omics Business Overview Table 168. Westlake Omics Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. Westlake Omics Modified Proteomics Service Product Portfolio Table 170. Westlake Omics Recent Development Table 171. CDI Labs Company Information Table 172. CDI Labs Business Overview Table 173. CDI Labs Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. CDI Labs Modified Proteomics Service Product Portfolio Table 175. CDI Labs Recent Development Table 176. Proteome Sciences Company Information Table 177. Proteome Sciences Business Overview Table 178. Proteome Sciences Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 179. Proteome Sciences Modified Proteomics Service Product Portfolio Table 180. Proteome Sciences Recent Development Table 181. Sapient Bioanalytics Company Information Table 182. Sapient Bioanalytics Business Overview Table 183. Sapient Bioanalytics Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 184. Sapient Bioanalytics Modified Proteomics Service Product Portfolio Table 185. Sapient Bioanalytics Recent Development Table 186. Proteomics International Company Information Table 187. Proteomics International Business Overview Table 188. Proteomics International Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 189. Proteomics International Modified Proteomics Service Product Portfolio Table 190. Proteomics International Recent Development Table 191. Cosmos Wisdom Company Information Table 192. Cosmos Wisdom Business Overview Table 193. Cosmos Wisdom Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 194. Cosmos Wisdom Modified Proteomics Service Product Portfolio Table 195. Cosmos Wisdom Recent Development Table 196. MRM Proteomics Company Information Table 197. MRM Proteomics Business Overview Table 198. MRM Proteomics Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 199. MRM Proteomics Modified Proteomics Service Product Portfolio Table 200. MRM Proteomics Recent Development Table 201. Sinotech Genomics Company Information Table 202. Sinotech Genomics Business Overview Table 203. Sinotech Genomics Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 204. Sinotech Genomics Modified Proteomics Service Product Portfolio Table 205. Sinotech Genomics Recent Development Table 206. Precision Biomarker Laboratories (PBL) Company Information Table 207. Precision Biomarker Laboratories (PBL) Business Overview Table 208. Precision Biomarker Laboratories (PBL) Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 209. Precision Biomarker Laboratories (PBL) Modified Proteomics Service Product Portfolio Table 210. Precision Biomarker Laboratories (PBL) Recent Development Table 211. PTM BIO Company Information Table 212. PTM BIO Business Overview Table 213. PTM BIO Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 214. PTM BIO Modified Proteomics Service Product Portfolio Table 215. PTM BIO Recent Development Table 216. Cell Signaling Technology (CST) Company Information Table 217. Cell Signaling Technology (CST) Business Overview Table 218. Cell Signaling Technology (CST) Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 219. Cell Signaling Technology (CST) Modified Proteomics Service Product Portfolio Table 220. Cell Signaling Technology (CST) Recent Development Table 221. APTBIO Company Information Table 222. APTBIO Business Overview Table 223. APTBIO Modified Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 224. APTBIO Modified Proteomics Service Product Portfolio Table 225. APTBIO Recent Development Table 226. Research Programs/Design for This Report Table 227. Authors List of This Report Table 228. Secondary Sources Table 229. Primary Sources List of Figures Figure 1. Modified Proteomics Service Product Image Figure 2. Global Modified Proteomics Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Modified Proteomics Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Phosphorylation Image Figure 8. Acetylation Image Figure 9. Ubiquitination Image Figure 10. Methylation Image Figure 11. Glycosylation Image Figure 12. Lactylation Image Figure 13. Redox Image Figure 14. Palmitoylation Image Figure 15. Others Image Figure 16. Global Modified Proteomics Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Modified Proteomics Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Modified Proteomics Service Sales Value Share by Type (2021-2032) Figure 19. Clinical Diagnostics Image Figure 20. Drug Discovery Image Figure 21. Others Image Figure 22. Global Modified Proteomics Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Modified Proteomics Service Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Modified Proteomics Service Sales Value Share by Application (2021-2032) Figure 25. Global Modified Proteomics Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 26. Global Modified Proteomics Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 27. North America Modified Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 28. North America Modified Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Europe Modified Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 30. Europe Modified Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Asia-Pacific Modified Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 32. Asia-Pacific Modified Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. South America Modified Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 34. South America Modified Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Middle East & Africa Modified Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 36. Middle East & Africa Modified Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 37. USA Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. USA Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. USA Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Canada Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Canada Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Canada Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Mexico Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Mexico Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Mexico Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Germany Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Germany Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Germany Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. France Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. France Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. France Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. U.K. Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. U.K. Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. U.K. Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Italy Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Italy Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Italy Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Spain Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Spain Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Spain Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Russia Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Russia Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Russia Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Netherlands Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Netherlands Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Netherlands Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Nordic Countries Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Nordic Countries Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Nordic Countries Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. China Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. China Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. China Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Japan Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Japan Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Japan Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. South Korea Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. South Korea Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. South Korea Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. India Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. India Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. India Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Australia Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Australia Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Australia Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Southeast Asia Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Southeast Asia Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Southeast Asia Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Brazil Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Brazil Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Brazil Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Argentina Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Argentina Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Argentina Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Chile Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Chile Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Chile Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Colombia Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Colombia Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Colombia Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Peru Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Peru Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Peru Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Saudi Arabia Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Israel Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Israel Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Israel Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. UAE Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. UAE Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. UAE Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Turkey Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Turkey Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Turkey Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Iran Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Iran Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Iran Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Egypt Modified Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Egypt Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Egypt Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Years Considered Figure 122. Research Process Figure 123. Key Executives Interviewed

Scope & coverage.

Types
  • Phosphorylation
  • Acetylation
  • Ubiquitination
  • Methylation
  • Glycosylation
  • Lactylation
  • Redox
  • Palmitoylation
  • Others
Applications
  • Clinical Diagnostics
  • Drug Discovery
  • Others
Companies covered
  • BGI Genomics
  • OmicScouts (Momentum Biotechnologies)
  • Biodesix
  • Shanghai OE Biotech
  • Crown Bioscience
  • Shanghai Bioprofile
  • Creative Proteomics
  • Inotiv
  • MtoZ-Biolabs
  • CellCarta
  • Biognosys
  • MS Bioworks
  • Charles River Laboratories
  • Metware Biotechnology
  • Novogene
  • Evotec
  • RxCelerate
  • Shanghai Majorbio Bio-Pharm
  • Lc-Bio Technologies
  • CD Genomics
  • Discovery Life Sciences
  • Applied Biomics
  • VProteomics
  • Allumiqs
  • Westlake Omics
  • CDI Labs
  • Proteome Sciences
  • Sapient Bioanalytics
  • Proteomics International
  • Cosmos Wisdom
  • MRM Proteomics
  • Sinotech Genomics
  • Precision Biomarker Laboratories (PBL)
  • PTM BIO
  • Cell Signaling Technology (CST)
  • APTBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Modified Proteomics Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Modified Proteomics Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Modified Proteomics Service Market Dynamics
  1. 2.1 Modified Proteomics Service Industry Trends
  2. 2.2 Modified Proteomics Service Industry Drivers
  3. 2.3 Modified Proteomics Service Industry Opportunities and Challenges
  4. 2.4 Modified Proteomics Service Industry Restraints
3 Modified Proteomics Service Market by Company
  1. 3.1 Global Modified Proteomics Service Company Revenue Ranking in 2025
  2. 3.2 Global Modified Proteomics Service Revenue by Company (2021-2026)
  3. 3.3 Global Modified Proteomics Service Company Ranking (2024-2026)
  4. 3.4 Global Modified Proteomics Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Modified Proteomics Service Company Product Type and Application
  6. 3.6 Global Modified Proteomics Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Modified Proteomics Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Modified Proteomics Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Modified Proteomics Service Market by Type
  1. 4.1 Modified Proteomics Service Type Introduction
  2. 4.1.1 Phosphorylation
  3. 4.1.2 Acetylation
  4. 4.1.3 Ubiquitination
  5. 4.1.4 Methylation
  6. 4.1.5 Glycosylation
  7. 4.1.6 Lactylation
  8. 4.1.7 Redox
  9. 4.1.8 Palmitoylation
  10. 4.1.9 Others
  11. 4.2 Global Modified Proteomics Service Sales Value by Type
  12. 4.2.1 Global Modified Proteomics Service Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global Modified Proteomics Service Sales Value by Type (2021-2032)
  14. 4.2.3 Global Modified Proteomics Service Sales Value Share by Type (2021-2032)
5 Modified Proteomics Service Market by Application
  1. 5.1 Modified Proteomics Service Application Introduction
  2. 5.1.1 Clinical Diagnostics
  3. 5.1.2 Drug Discovery
  4. 5.1.3 Others
  5. 5.2 Global Modified Proteomics Service Sales Value by Application
  6. 5.2.1 Global Modified Proteomics Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Modified Proteomics Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Modified Proteomics Service Sales Value Share by Application (2021-2032)
6 Modified Proteomics Service Regional Value Analysis
  1. 6.1 Global Modified Proteomics Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Modified Proteomics Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Modified Proteomics Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Modified Proteomics Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Modified Proteomics Service Sales Value (2021-2032)
  7. 6.3.2 North America Modified Proteomics Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Modified Proteomics Service Sales Value (2021-2032)
  10. 6.4.2 Europe Modified Proteomics Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Modified Proteomics Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Modified Proteomics Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Modified Proteomics Service Sales Value (2021-2032)
  16. 6.6.2 South America Modified Proteomics Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Modified Proteomics Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Modified Proteomics Service Sales Value Share by Country, 2025 VS 2032
7 Modified Proteomics Service Country-level Value Analysis
  1. 7.1 Global Modified Proteomics Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Modified Proteomics Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Modified Proteomics Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Modified Proteomics Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Modified Proteomics Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Modified Proteomics Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Modified Proteomics Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BGI Genomics
  2. 8.1.1 BGI Genomics Company Information
  3. 8.1.2 BGI Genomics Business Overview
  4. 8.1.3 BGI Genomics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BGI Genomics Modified Proteomics Service Product Portfolio
  6. 8.1.5 BGI Genomics Recent Developments
  7. 8.2 OmicScouts (Momentum Biotechnologies)
  8. 8.2.1 OmicScouts (Momentum Biotechnologies) Company Information
  9. 8.2.2 OmicScouts (Momentum Biotechnologies) Business Overview
  10. 8.2.3 OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Product Portfolio
  12. 8.2.5 OmicScouts (Momentum Biotechnologies) Recent Developments
  13. 8.3 Biodesix
  14. 8.3.1 Biodesix Company Information
  15. 8.3.2 Biodesix Business Overview
  16. 8.3.3 Biodesix Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Biodesix Modified Proteomics Service Product Portfolio
  18. 8.3.5 Biodesix Recent Developments
  19. 8.4 Shanghai OE Biotech
  20. 8.4.1 Shanghai OE Biotech Company Information
  21. 8.4.2 Shanghai OE Biotech Business Overview
  22. 8.4.3 Shanghai OE Biotech Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai OE Biotech Modified Proteomics Service Product Portfolio
  24. 8.4.5 Shanghai OE Biotech Recent Developments
  25. 8.5 Crown Bioscience
  26. 8.5.1 Crown Bioscience Company Information
  27. 8.5.2 Crown Bioscience Business Overview
  28. 8.5.3 Crown Bioscience Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Crown Bioscience Modified Proteomics Service Product Portfolio
  30. 8.5.5 Crown Bioscience Recent Developments
  31. 8.6 Shanghai Bioprofile
  32. 8.6.1 Shanghai Bioprofile Company Information
  33. 8.6.2 Shanghai Bioprofile Business Overview
  34. 8.6.3 Shanghai Bioprofile Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Bioprofile Modified Proteomics Service Product Portfolio
  36. 8.6.5 Shanghai Bioprofile Recent Developments
  37. 8.7 Creative Proteomics
  38. 8.7.1 Creative Proteomics Company Information
  39. 8.7.2 Creative Proteomics Business Overview
  40. 8.7.3 Creative Proteomics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Creative Proteomics Modified Proteomics Service Product Portfolio
  42. 8.7.5 Creative Proteomics Recent Developments
  43. 8.8 Inotiv
  44. 8.8.1 Inotiv Company Information
  45. 8.8.2 Inotiv Business Overview
  46. 8.8.3 Inotiv Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Inotiv Modified Proteomics Service Product Portfolio
  48. 8.8.5 Inotiv Recent Developments
  49. 8.9 MtoZ-Biolabs
  50. 8.9.1 MtoZ-Biolabs Company Information
  51. 8.9.2 MtoZ-Biolabs Business Overview
  52. 8.9.3 MtoZ-Biolabs Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MtoZ-Biolabs Modified Proteomics Service Product Portfolio
  54. 8.9.5 MtoZ-Biolabs Recent Developments
  55. 8.10 CellCarta
  56. 8.10.1 CellCarta Company Information
  57. 8.10.2 CellCarta Business Overview
  58. 8.10.3 CellCarta Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CellCarta Modified Proteomics Service Product Portfolio
  60. 8.10.5 CellCarta Recent Developments
  61. 8.11 Biognosys
  62. 8.11.1 Biognosys Company Information
  63. 8.11.2 Biognosys Business Overview
  64. 8.11.3 Biognosys Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biognosys Modified Proteomics Service Product Portfolio
  66. 8.11.5 Biognosys Recent Developments
  67. 8.12 MS Bioworks
  68. 8.12.1 MS Bioworks Company Information
  69. 8.12.2 MS Bioworks Business Overview
  70. 8.12.3 MS Bioworks Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 MS Bioworks Modified Proteomics Service Product Portfolio
  72. 8.12.5 MS Bioworks Recent Developments
  73. 8.13 Charles River Laboratories
  74. 8.13.1 Charles River Laboratories Company Information
  75. 8.13.2 Charles River Laboratories Business Overview
  76. 8.13.3 Charles River Laboratories Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Charles River Laboratories Modified Proteomics Service Product Portfolio
  78. 8.13.5 Charles River Laboratories Recent Developments
  79. 8.14 Metware Biotechnology
  80. 8.14.1 Metware Biotechnology Company Information
  81. 8.14.2 Metware Biotechnology Business Overview
  82. 8.14.3 Metware Biotechnology Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Metware Biotechnology Modified Proteomics Service Product Portfolio
  84. 8.14.5 Metware Biotechnology Recent Developments
  85. 8.15 Novogene
  86. 8.15.1 Novogene Company Information
  87. 8.15.2 Novogene Business Overview
  88. 8.15.3 Novogene Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Novogene Modified Proteomics Service Product Portfolio
  90. 8.15.5 Novogene Recent Developments
  91. 8.16 Evotec
  92. 8.16.1 Evotec Company Information
  93. 8.16.2 Evotec Business Overview
  94. 8.16.3 Evotec Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Evotec Modified Proteomics Service Product Portfolio
  96. 8.16.5 Evotec Recent Developments
  97. 8.17 RxCelerate
  98. 8.17.1 RxCelerate Company Information
  99. 8.17.2 RxCelerate Business Overview
  100. 8.17.3 RxCelerate Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 RxCelerate Modified Proteomics Service Product Portfolio
  102. 8.17.5 RxCelerate Recent Developments
  103. 8.18 Shanghai Majorbio Bio-Pharm
  104. 8.18.1 Shanghai Majorbio Bio-Pharm Company Information
  105. 8.18.2 Shanghai Majorbio Bio-Pharm Business Overview
  106. 8.18.3 Shanghai Majorbio Bio-Pharm Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Shanghai Majorbio Bio-Pharm Modified Proteomics Service Product Portfolio
  108. 8.18.5 Shanghai Majorbio Bio-Pharm Recent Developments
  109. 8.19 Lc-Bio Technologies
  110. 8.19.1 Lc-Bio Technologies Company Information
  111. 8.19.2 Lc-Bio Technologies Business Overview
  112. 8.19.3 Lc-Bio Technologies Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Lc-Bio Technologies Modified Proteomics Service Product Portfolio
  114. 8.19.5 Lc-Bio Technologies Recent Developments
  115. 8.20 CD Genomics
  116. 8.20.1 CD Genomics Company Information
  117. 8.20.2 CD Genomics Business Overview
  118. 8.20.3 CD Genomics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 CD Genomics Modified Proteomics Service Product Portfolio
  120. 8.20.5 CD Genomics Recent Developments
  121. 8.21 Discovery Life Sciences
  122. 8.21.1 Discovery Life Sciences Company Information
  123. 8.21.2 Discovery Life Sciences Business Overview
  124. 8.21.3 Discovery Life Sciences Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Discovery Life Sciences Modified Proteomics Service Product Portfolio
  126. 8.21.5 Discovery Life Sciences Recent Developments
  127. 8.22 Applied Biomics
  128. 8.22.1 Applied Biomics Company Information
  129. 8.22.2 Applied Biomics Business Overview
  130. 8.22.3 Applied Biomics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Applied Biomics Modified Proteomics Service Product Portfolio
  132. 8.22.5 Applied Biomics Recent Developments
  133. 8.23 VProteomics
  134. 8.23.1 VProteomics Company Information
  135. 8.23.2 VProteomics Business Overview
  136. 8.23.3 VProteomics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 VProteomics Modified Proteomics Service Product Portfolio
  138. 8.23.5 VProteomics Recent Developments
  139. 8.24 Allumiqs
  140. 8.24.1 Allumiqs Company Information
  141. 8.24.2 Allumiqs Business Overview
  142. 8.24.3 Allumiqs Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Allumiqs Modified Proteomics Service Product Portfolio
  144. 8.24.5 Allumiqs Recent Developments
  145. 8.25 Westlake Omics
  146. 8.25.1 Westlake Omics Company Information
  147. 8.25.2 Westlake Omics Business Overview
  148. 8.25.3 Westlake Omics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Westlake Omics Modified Proteomics Service Product Portfolio
  150. 8.25.5 Westlake Omics Recent Developments
  151. 8.26 CDI Labs
  152. 8.26.1 CDI Labs Company Information
  153. 8.26.2 CDI Labs Business Overview
  154. 8.26.3 CDI Labs Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  155. 8.26.4 CDI Labs Modified Proteomics Service Product Portfolio
  156. 8.26.5 CDI Labs Recent Developments
  157. 8.27 Proteome Sciences
  158. 8.27.1 Proteome Sciences Company Information
  159. 8.27.2 Proteome Sciences Business Overview
  160. 8.27.3 Proteome Sciences Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Proteome Sciences Modified Proteomics Service Product Portfolio
  162. 8.27.5 Proteome Sciences Recent Developments
  163. 8.28 Sapient Bioanalytics
  164. 8.28.1 Sapient Bioanalytics Company Information
  165. 8.28.2 Sapient Bioanalytics Business Overview
  166. 8.28.3 Sapient Bioanalytics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Sapient Bioanalytics Modified Proteomics Service Product Portfolio
  168. 8.28.5 Sapient Bioanalytics Recent Developments
  169. 8.29 Proteomics International
  170. 8.29.1 Proteomics International Company Information
  171. 8.29.2 Proteomics International Business Overview
  172. 8.29.3 Proteomics International Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Proteomics International Modified Proteomics Service Product Portfolio
  174. 8.29.5 Proteomics International Recent Developments
  175. 8.30 Cosmos Wisdom
  176. 8.30.1 Cosmos Wisdom Company Information
  177. 8.30.2 Cosmos Wisdom Business Overview
  178. 8.30.3 Cosmos Wisdom Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Cosmos Wisdom Modified Proteomics Service Product Portfolio
  180. 8.30.5 Cosmos Wisdom Recent Developments
  181. 8.31 MRM Proteomics
  182. 8.31.1 MRM Proteomics Company Information
  183. 8.31.2 MRM Proteomics Business Overview
  184. 8.31.3 MRM Proteomics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  185. 8.31.4 MRM Proteomics Modified Proteomics Service Product Portfolio
  186. 8.31.5 MRM Proteomics Recent Developments
  187. 8.32 Sinotech Genomics
  188. 8.32.1 Sinotech Genomics Company Information
  189. 8.32.2 Sinotech Genomics Business Overview
  190. 8.32.3 Sinotech Genomics Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  191. 8.32.4 Sinotech Genomics Modified Proteomics Service Product Portfolio
  192. 8.32.5 Sinotech Genomics Recent Developments
  193. 8.33 Precision Biomarker Laboratories (PBL)
  194. 8.33.1 Precision Biomarker Laboratories (PBL) Company Information
  195. 8.33.2 Precision Biomarker Laboratories (PBL) Business Overview
  196. 8.33.3 Precision Biomarker Laboratories (PBL) Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  197. 8.33.4 Precision Biomarker Laboratories (PBL) Modified Proteomics Service Product Portfolio
  198. 8.33.5 Precision Biomarker Laboratories (PBL) Recent Developments
  199. 8.34 PTM BIO
  200. 8.34.1 PTM BIO Company Information
  201. 8.34.2 PTM BIO Business Overview
  202. 8.34.3 PTM BIO Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  203. 8.34.4 PTM BIO Modified Proteomics Service Product Portfolio
  204. 8.34.5 PTM BIO Recent Developments
  205. 8.35 Cell Signaling Technology (CST)
  206. 8.35.1 Cell Signaling Technology (CST) Company Information
  207. 8.35.2 Cell Signaling Technology (CST) Business Overview
  208. 8.35.3 Cell Signaling Technology (CST) Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  209. 8.35.4 Cell Signaling Technology (CST) Modified Proteomics Service Product Portfolio
  210. 8.35.5 Cell Signaling Technology (CST) Recent Developments
  211. 8.36 APTBIO
  212. 8.36.1 APTBIO Company Information
  213. 8.36.2 APTBIO Business Overview
  214. 8.36.3 APTBIO Modified Proteomics Service Revenue and Gross Margin (2021-2026)
  215. 8.36.4 APTBIO Modified Proteomics Service Product Portfolio
  216. 8.36.5 APTBIO Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst